Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Condition(s):Urothelial Carcinoma; CancerLast Updated:May 30, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Urothelial Carcinoma; CancerLast Updated:May 30, 2023Recruiting
Condition(s):Urothelial CarcinomaLast Updated:October 24, 2018Terminated
Condition(s):Urothelial CarcinomaLast Updated:February 6, 2024Active, not recruiting
Condition(s):Urothelial Carcinoma; Solid TumorLast Updated:December 28, 2023Recruiting
Condition(s):Urothelial CarcinomaLast Updated:September 1, 2017Completed
Condition(s):Bladder CancerLast Updated:July 11, 2022Terminated
Condition(s):Bladder Cancer; Urothelial CarcinomaLast Updated:March 22, 2024Recruiting
Condition(s):Urothelial CarcinomaLast Updated:September 25, 2014Completed
Condition(s):Urothelial CarcinomaLast Updated:March 4, 2020Completed
Condition(s):Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7; Stage I Bladder Urothelial Carcinoma AJCC v6 and v7Last Updated:July 28, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.